Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023) | McDonnell Boehnen Hulbert & Berghoff LLP

Proper construction of claim limitations reciting the chemical property of pH (which denotes the concentration of hydrogen ions in a solution as an indication of acidity) has arisen...

Related Keywords

United States ,Teva Pharms ,Actelion Flolan ,Circuit In Actelion Pharmaceuticals Ltd ,Rainbow Techs Inc ,Supreme Court ,District Court ,United States Inc ,Mylan Pharmaceuticals Inc ,Sandoz Inc ,Mcdonnell Boehnen Hulbert Berghoff ,Mcdonnell Boehnen Hulbert ,Federal Circuit ,Davis Chemical ,Actelion Pharmaceuticals ,Pharmaceuticals Inc ,Judge Stoll ,Judges Reyna ,Circuit Judges Reyna ,Circuit Judge ,